XML 15 R4.htm IDEA: XBRL DOCUMENT v3.20.2
Statements of Operations - USD ($)
 3 Months Ended 9 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Sep. 30, 2020
Sep. 30, 2019
Operating expenses:        
Research and development $ 718,898 $ 2,013 $ 1,641,822 $ 14,074
General and administrative 884,859 239,781 3,088,726 720,586
Total operating expenses 1,603,757 241,794 4,730,548 734,660
Operating loss (1,603,757) (241,794) (4,730,548) (734,660)
Other income (expense):        
Change in fair value of derivative liability     (26,500) (26,500)
Interest income (expense), net 10,500 (12,327) 47,012 (28,564)
Grant income 586,903   952,602  
Total other income (expense) 597,403 (12,327) 973,114 (55,064)
Loss before income taxes (1,006,354) (254,121) (3,757,434) (789,724)
Income tax expense (benefit) 0 0 0 0
Net loss $ (1,006,354) $ (254,121) $ (3,757,434) $ (789,724)
Basic and diluted loss per common share $ (0.15) $ (0.90) $ (0.61) $ (2.79)
Weighted average number of common shares outstanding, basic and diluted 6,871,554 282,614 6,113,400 282,614